Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
0.4559
-0.0088 (-1.89%)
At close: Apr 2, 2026, 4:00 PM EDT
0.4467
-0.0092 (-2.02%)
After-hours: Apr 2, 2026, 7:56 PM EDT
Fractyl Health Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
101
Market Cap
72.33M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 93.00K | -27.00K | -22.50% |
| Dec 31, 2023 | 120.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pelthos Therapeutics | 16.80M |
| BeyondSpring | 1.88M |
| Coeptis Therapeutics Holdings | 1.36M |
| NRx Pharmaceuticals | 1.23M |
| MediciNova | 409.66K |
| eXoZymes | -700.00 |
GUTS News
- 10 days ago - Fractyl Health, Inc. (GUTS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 18 days ago - Fractyl Health to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Updates on March 24, 2026 - GlobeNewsWire
- 5 weeks ago - Fractyl Health Completes Randomization in REMAIN-1 Pivotal Cohort of Revita® for Post-GLP-1 Weight Maintenance - GlobeNewsWire
- 2 months ago - Fractyl Health: Unreasonably Low Market Expectations Create A Trading Opportunity Towards 2026 Catalysts - Seeking Alpha
- 2 months ago - Fractyl Health, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – GUTS - Business Wire
- 2 months ago - Fractyl Health Shares Drop, Eyes New FDA Route For Its Lead Product - Benzinga
- 2 months ago - Fractyl Health, Inc. (GUTS) Discusses REMAIN-1 Midpoint Cohort Results on Revita for Weight Maintenance After GLP-1 Discontinuation Transcript - Seeking Alpha
- 2 months ago - Fractyl Health Announces Compelling 6-Month Randomized REMAIN-1 Midpoint Data Showing Durable Weight Maintenance with Revita® After GLP-1 Discontinuation - GlobeNewsWire